These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 934152)

  • 1. [Prenatal membrane syndrome prevention using glucocorticoids].
    von Loewenich V; Halberstadt E; Eckert H; Gerner R
    Monatsschr Kinderheilkd (1902); 1976 May; 124(5):459-60. PubMed ID: 934152
    [No Abstract]   [Full Text] [Related]  

  • 2. [Critical study of the use of glucocorticoids in the prevention of hyaline membrane disease].
    Leroy JL
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(1):152-7. PubMed ID: 6896522
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
    Liggins GC; Howie RN
    Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasminogen in the prevention of hyaline membrane disease.
    Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Irwin ; Bross DJ; Jung OS; Mink IB; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):341-4. PubMed ID: 4582209
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of hyaline membrane disease.
    Avery ME
    Pediatrics; 1972 Oct; 50(4):513-4. PubMed ID: 5073005
    [No Abstract]   [Full Text] [Related]  

  • 7. Newer strategies in the prevention of hyaline membrane disease.
    Willett LD
    Nebr Med J; 1994 Aug; 79(8):303-4. PubMed ID: 7990997
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of idiopathic respiratory distress (hyaline membrane disease)].
    Amiel-Tison C; Tchobroutsky C
    Rev Prat; 1981 Jan; 31(5):345-8, 351. PubMed ID: 7466260
    [No Abstract]   [Full Text] [Related]  

  • 9. Antepartum prevention of respiratory distress syndrome (hyaline membrane disease).
    Sahu S
    J Iowa Med Soc; 1976 Dec; 66(12):481-3, 485-6. PubMed ID: 1036747
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of the hyaline membrane syndrome--indications and results (proceedings)].
    Halberstadt E; Gerner R; Eckert H; von Löwenich V
    Arch Gynakol; 1977 Jul; 224(1-4):209-10. PubMed ID: 579782
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of hyaline membrane disease.
    Ackerman BD
    Pediatr Ann; 1978 Mar; 7(3):195-200. PubMed ID: 634630
    [No Abstract]   [Full Text] [Related]  

  • 12. [The behaviour of endocrinal parameters under prophylaxis of hyaline membrane disease with glucocorticoids (author's transl)].
    Gerner R; Halberstadt E
    Z Geburtshilfe Perinatol; 1980 Aug; 184(4):262-6. PubMed ID: 6258342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of the respiratory distress syndrome of the newborn. Value of antepartum treatment with glucocorticoids].
    Fargier P; Salle B; Baud ; Gagnaire JC; Arnaud P; Magnin P
    Nouv Presse Med; 1974 Jun; 3(25):1595-1597. PubMed ID: 4602249
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prenatal application of colestone for prevention of hyalin membranes (author's transl)].
    Velemínský M; Lindner J; Blazek K; Krykorka P
    Cesk Gynekol; 1977 Feb; 42(1):48-50. PubMed ID: 844114
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of steroid therapy in the prevention of respiratory distress syndrome in the newborn].
    Szabó I; Csaba I; Novák P; Drozgyik I
    Orv Hetil; 1977 Mar; 118(10):566-8. PubMed ID: 840473
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in fetal lung maturity after maternal treatment with glucocorticoids].
    Gherzi R; Cottafavi M
    Minerva Ginecol; 1979 Nov; 31(11):815-20. PubMed ID: 263702
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ante partum prevention of hyaline membrane disease in the premature infants].
    Ditesheim PJ
    Gynakol Rundsch; 1977; 17(2):106-13. PubMed ID: 560332
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants].
    Saule H
    Med Klin; 1975 Mar; 70(10):409-15. PubMed ID: 1091827
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of hyaline membrane disease with sopolkort].
    Tokin R; Popova A; Ivanova S; Kozovski I; Iakov I
    Akush Ginekol (Sofiia); 1980; 19(1):25-9. PubMed ID: 7377510
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dose-effect curves of glucocorticoids for the prenatal prevention of the hyaline membrane syndrome (proceedings)].
    Gerner R; Halberstadt E; Schuhmann R; Schwarz H
    Arch Gynakol; 1977 Jul; 224(1-4):210-1. PubMed ID: 245279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.